We are live on
!
Find out more
TCM
Tygh Capital Management Portfolio holdings
AUM
$782M
1-Year Est. Return
39.44%
This Fund
S&P 500
This Quarter
Est. Return
-18.79%
1 Year Est. Return
+39.44%
3 Year Est. Return
+251.35%
5 Year Est. Return
+417.76%
10 Year Est. Return
–
AUM
$446M
AUM Growth
-$159M
(-26%)
Cap. Flow
-$24.6M
Cap. Flow
% of AUM
-5.52%
Top 10 Holdings %
Top 10 Hldgs %
26.16%
Holding
90
New
15
Increased
38
Reduced
20
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$8.73M |
| 2 |
NATI
National Instruments Corp
NATI
|
+$7.14M |
| 3 |
TFI International
TFII
|
+$5.92M |
| 4 |
Casella Waste Systems
CWST
|
+$5.56M |
| 5 |
AMED
Amedisys
AMED
|
+$5.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MasTec
MTZ
|
+$10.4M |
| 2 |
Brinker International
EAT
|
+$9.67M |
| 3 |
OneSpaWorld
OSW
|
+$7.78M |
| 4 |
United Parks & Resorts
PRKS
|
+$7.74M |
| 5 |
Insperity
NSP
|
+$6.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.06% |
| 2 | Healthcare | 26.32% |
| 3 | Industrials | 25.16% |
| 4 | Consumer Discretionary | 5.86% |
| 5 | Financials | 4.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bio-Rad Laboratories Class A
BIO
$8.8B
| $17M | 3.81% |
48,524
+396
| +0.8% | +$146K |
|
2
Kinsale Capital Group
KNSL
$8.44B
| $13.3M | 2.99% |
127,683
-56,447
| -31% | -$6.36M |
|
3
CACI
CACI
$11.2B
| $12.9M | 2.9% |
61,285
+6,136
| +11% | +$1.52M |
|
4
Repligen
RGEN
$8.53B
| $12.5M | 2.81% |
129,691
+666
| +0.5% | +$64.3K |
|
|
5
Ligand Pharmaceuticals
LGND
$5.98B
| $11M | 2.47% |
243,323
+154,081
| +173% | +$8.73M |
|
6
Omnicell
OMCL
$1.95B
| $10.5M | 2.35% |
159,702
+58,726
| +58% | +$4.68M |
|
7
Genpact
G
$5.89B
| $10M | 2.25% |
343,400
+1,917
| +0.6% | +$75K |
|
8
Teladoc Health
TDOC
$1.65B
| $9.9M | 2.22% |
63,856
-41,001
| -39% | -$4.77M |
|
9
Onto Innovation
ONTO
$11.8B
| $9.82M | 2.2% |
330,921
+70,888
| +27% | +$2.42M |
|
|
HMSY
10
DELISTED
HMS Holdings Corp.
HMSY
| $9.64M | 2.16% |
381,423
+1,905
| +0.5% | +$49.6K |
|
|
11
Casella Waste Systems
CWST
$5.71B
| $9.49M | 2.13% |
242,867
+114,657
| +89% | +$5.56M |
|
12
WillScot Mobile Mini Holdings
WSC
$4.8B
| $9.26M | 2.08% |
913,908
-116,218
| -11% | -$1.89M |
|
13
Maximus
MMS
$3.31B
| $9.05M | 2.03% |
155,592
+60,451
| +64% | +$4.1M |
|
14
Applied Industrial Technologies
AIT
$12.8B
| $8.75M | 1.96% |
191,349
+51,286
| +37% | +$3.03M |
|
15
Quanta Services
PWR
$87.9B
| $8.65M | 1.94% |
272,472
+1,563
| +0.6% | +$58.1K |
|
|
CONE
16
DELISTED
CyrusOne Inc Common Stock
CONE
| $8.64M | 1.94% |
139,877
+15,230
| +12% | +$930K |
|
17
Viavi Solutions
VIAV
$8.64B
| $8.5M | 1.91% |
758,205
+139,065
| +22% | +$1.89M |
|
18
Charles River Laboratories
CRL
$11.4B
| $8.47M | 1.9% |
67,111
+290
| +0.4% | +$43.5K |
|
19
Emergent Biosolutions
EBS
$374M
| $8.26M | 1.85% |
142,732
+25,570
| +22% | +$1.47M |
|
|
PRAH
20
DELISTED
PRA Health Sciences, Inc.
PRAH
| $8.25M | 1.85% |
99,309
-49,513
| -33% | -$4.83M |
|
21
Strategic Education
STRA
$1.83B
| $8.24M | 1.85% |
58,983
+17,254
| +41% | +$2.64M |
|
|
LHCG
22
DELISTED
LHC Group LLC
LHCG
| $7.88M | 1.77% |
56,217
+22,276
| +66% | +$3.1M |
|
23
Tower Semiconductor
TSEM
$23.3B
| $7.84M | 1.76% |
492,353
+115,963
| +31% | +$2.41M |
|
24
Mercury Systems
MRCY
$6B
| $7.56M | 1.69% |
105,976
+23,258
| +28% | +$1.76M |
|
25
State Street SPDR S&P Biotech ETF
XBI
$10.1B
| $7.54M | 1.69% |
97,376
+1,054
| +1% | +$93.3K |
|
Similar funds
IVP
FMBTD
EHPM
VMV
SIM
HAM
VIMU
AC
Tygh Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Tygh Capital Management held 90 positions worth $446M, down 26% from $606M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Tygh Capital Management withdrew a net $24.6M in Q1 2020, closing 17 positions and reducing 20 holdings. Its most notable exit was MasTec, an estimated $10.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Tygh Capital Management opened a new position in National Instruments Corp worth $5.91M.
- Tygh Capital Management's largest Q1 2020 buy was National Instruments Corp: 178,715 shares worth $5.91M.
- Tygh Capital Management added most to Ligand Pharmaceuticals in Q1 2020, an estimated $8.73M increase.
- Tygh Capital Management's biggest Q1 2020 reduction was Kinsale Capital Group, cutting an estimated $6.36M.
- Tygh Capital Management fully exited MasTec in Q1 2020, selling an estimated $10.4M.
- Tygh Capital Management's ten largest holdings make up 26% of its $446M portfolio in Q1 2020.
- Tygh Capital Management opened 15 new positions and closed 17 in Q1 2020.
- Tygh Capital Management's portfolio value fell 26% quarter-over-quarter to $446M.
Based on Tygh Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.